DePuy Orthopaedics

Clinical trials sponsored by DePuy Orthopaedics, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Orthopaedic device division of Johnson & Johnson, focusing on joint replacement and trauma products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New cementless knee implant aims to improve mobility in osteoarthritis patients Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet finished but already full! 3 Terminated 1

New hip implant put to the test: will it stay put?

Knowledge-focused Stopped early

This study looked at a specific hip implant shell (the Pinnacle Acetabular Shell) used in total hip replacement. Researchers wanted to see how much the implant moved (migrated) over two years using a special X-ray technique called RSA. They also tracked how patients felt and func…

Sponsor: DePuy Orthopaedics • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:05 UTC

DePuy Orthopaedics

Upcoming readouts

New hip implant put to the test: will it stay put?